COMMUNIQUÉS West-GlobeNewswire
-
Indulge Sonoma Returns for an Unforgettable Celebration of Sonoma County's Culinary Excellence
23/07/2026 -
Precision Neuroscience™ Appoints John Donoghue, Pioneer of Brain–Computer Interfaces, as Scientific Advisor
23/07/2026 -
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026 -
Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
23/07/2026 -
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
23/07/2026 -
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
23/07/2026 -
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
23/07/2026 -
ApolloMD Earns National and Atlanta Best and Brightest Companies to Work For® Honors for Second Straight Year
23/07/2026 -
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development
23/07/2026 -
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
23/07/2026 -
First American Equipment Finance renews HFMA Peer Review designation
23/07/2026 -
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026 -
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
23/07/2026 -
Correction: Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
23/07/2026 -
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
23/07/2026 -
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
23/07/2026 -
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23/07/2026 -
Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
23/07/2026 -
AAVantgarde Announces Participation of Founder and CSO, Prof. Alberto Auricchio at the 32nd Annual Meeting of the Japanese Society for Gene and Cell Therapy
23/07/2026
Pages